Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma
暂无分享,去创建一个
D. Mehrotra | S. Mukherjee | R. Jaiswal | S. Singh | Sameer Gupta | Naina Kumari | Rashmi Kumar | Raghwendra Pratap Singh
[1] Hongzhong Li,et al. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies , 2022, Journal of Hematology & Oncology.
[2] D. Costea,et al. Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of Malassezia as an Independent and Favorable Predictor of Overall Survival , 2021, Frontiers in Cellular and Infection Microbiology.
[3] G. Nair,et al. The Vaginal Microbial Signatures of Preterm Birth Delivery in Indian Women , 2021, Frontiers in Cellular and Infection Microbiology.
[4] M. Sohrabi,et al. Role of microbiota-derived short-chain fatty acids in cancer development and prevention. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] C. Eng,et al. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer , 2021, Genome medicine.
[6] J. Wargo,et al. Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect , 2021, Cancer Immunology Research.
[7] J. Hasty,et al. The microbiome and human cancer , 2021, Science.
[8] Yanbing Wang,et al. The role of Short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. , 2021, Pharmacological research.
[9] S. Morré,et al. The Association Between Vaginal Microbiota Dysbiosis, Bacterial Vaginosis, and Aerobic Vaginitis, and Adverse Pregnancy Outcomes of Women Living in Sub-Saharan Africa: A Systematic Review , 2020, Frontiers in Public Health.
[10] Lanjuan Li,et al. The Intestinal Microbiota and Colorectal Cancer , 2020, Frontiers in Immunology.
[11] S. Nathan,et al. Advantages and Limitations of 16S rRNA Next-Generation Sequencing for Pathogen Identification in the Diagnostic Microbiology Laboratory: Perspectives from a Middle-Income Country , 2020, Diagnostics.
[12] C. Huang,et al. Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review , 2020, Frontiers in Oncology.
[13] Hilal Bashir,et al. Emerging role of microbiota in immunomodulation and cancer immunotherapy. , 2020, Seminars in cancer biology.
[14] Charles Nkufi Tango,et al. Taxonomic and Functional Differences in Cervical Microbiome Associated with Cervical Cancer Development , 2020, Scientific Reports.
[15] Noam Shental,et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.
[16] Ligong Chen,et al. Memory T cells: strategies for optimizing tumor immunotherapy , 2020, Protein & Cell.
[17] H. Harmsen,et al. Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients , 2020, Journal of clinical medicine.
[18] D. Longley,et al. Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[19] U. Gophna,et al. Fecal microbiome signatures of pancreatic cancer patients , 2019, Scientific Reports.
[20] Hongwei Li,et al. Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer , 2019, International journal of biological sciences.
[21] F. Greten,et al. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. , 2019, Immunity.
[22] W. Borgnakke,et al. The Microbiome of Oral Squamous Cell Carcinomas: a Functional Perspective , 2019, Current Oral Health Reports.
[23] Guangxiu Liu,et al. Relationship between intestinal microbial dysbiosis and primary liver cancer. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.
[24] Yong Zhou,et al. Salivary Microbial Dysbiosis is Associated with Systemic Inflammatory Markers and Predicted Oral Metabolites in Non-Small Cell Lung Cancer Patients , 2019, Journal of Cancer.
[25] K. Faber,et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases , 2019, Front. Immunol..
[26] Rob Knight,et al. Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations. , 2019, Trends in microbiology.
[27] H. Nishikawa,et al. Regulatory T cells in cancer immunosuppression — implications for anticancer therapy , 2019, Nature Reviews Clinical Oncology.
[28] P. Chaturvedi,et al. Role of Poor Oral Hygiene in Causation of Oral Cancer—a Review of Literature , 2018, Indian Journal of Surgical Oncology.
[29] M. Morrison,et al. The Performance of an Oral Microbiome Biomarker Panel in Predicting Oral Cavity and Oropharyngeal Cancers , 2018, Front. Cell. Infect. Microbiol..
[30] T. Meirson,et al. Oral inflammation promotes oral squamous cell carcinoma invasion , 2018, Oncotarget.
[31] C. Liao,et al. Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging , 2018, Front. Microbiol..
[32] S. Pushalkar,et al. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. , 2018, Cancer discovery.
[33] R. Hayes,et al. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer , 2018, JAMA oncology.
[34] J. Slotta-Huspenina,et al. Gut microbiota modulate T cell trafficking into human colorectal cancer , 2018, Gut.
[35] R. Isaacson,et al. Deciphering Diversity Indices for a Better Understanding of Microbial Communities. , 2017, Journal of microbiology and biotechnology.
[36] Timothy L. Tickle,et al. Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer , 2017, Scientific Reports.
[37] Hsien-Da Huang,et al. Bacterial alterations in salivary microbiota and their association in oral cancer , 2017, Scientific Reports.
[38] D. Relman,et al. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data , 2017, Microbiome.
[39] Chenping Zhang,et al. Variations in oral microbiota associated with oral cancer , 2017, Scientific Reports.
[40] Shan Jiang,et al. Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future. , 2017, Current problems in cancer.
[41] O. Dizdar,et al. Increased cancer risk in patients with periodontitis , 2017, Current medical research and opinion.
[42] M. Redinbo,et al. The role of the microbiome in cancer development and therapy , 2017, CA: a cancer journal for clinicians.
[43] H. Saluja,et al. The prevalence of squamous cell carcinoma in different sites of oral cavity at our Rural Health Care Centre in Loni, Maharashtra – a retrospective 10-year study , 2017, Contemporary oncology.
[44] J. Madrigal,et al. B cell regulation in cancer and anti-tumor immunity , 2017, Cellular &Molecular Immunology.
[45] Tsute Chen,et al. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma , 2017, Scientific Reports.
[46] Xiang Gao,et al. A Bayesian taxonomic classification method for 16S rRNA gene sequences with improved species-level accuracy , 2017, BMC Bioinformatics.
[47] D. Missé,et al. Infections and cancer: the “fifty shades of immunity” hypothesis , 2017, BMC Cancer.
[48] B. Burkey,et al. Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas , 2017, Genome Medicine.
[49] R. Vivek,et al. Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients , 2016, npj Biofilms and Microbiomes.
[50] D. Sidransky,et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment , 2016, Oncotarget.
[51] N. Johnson,et al. Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria , 2016, Journal of oral microbiology.
[52] Bin Shang,et al. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis , 2015, Scientific Reports.
[53] Michael Elkin,et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model , 2015, Oncotarget.
[54] Koichi Hirata,et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis , 2015, Oncotarget.
[55] Bernard M. Corfe,et al. Dysbiosis of the gut microbiota in disease , 2015, Microbial ecology in health and disease.
[56] Shunsuke Takahashi,et al. Development of a Prokaryotic Universal Primer for Simultaneous Analysis of Bacteria and Archaea Using Next-Generation Sequencing , 2014, PloS one.
[57] Adam B. Olshen,et al. Changes in Abundance of Oral Microbiota Associated with Oral Cancer , 2014, PloS one.
[58] M. Hallek,et al. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer , 2014, Oncotarget.
[59] Jizhong Zhou,et al. Phylogenetic and functional gene structure shifts of the oral microbiomes in periodontitis patients , 2014, The ISME Journal.
[60] Shashikanth Hegde,et al. Poor periodontal health: A cancer risk? , 2013, Journal of Indian Society of Periodontology.
[61] Yong-Deok Kim,et al. The impact factors on 5-year survival rate in patients operated with oral cancer , 2013, Journal of the Korean Association of Oral and Maxillofacial Surgeons.
[62] Susan Holmes,et al. phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.
[63] Y. Ko,et al. The neoplastic impact of tobacco‐free betel‐quid on the histological type and the anatomical site of aerodigestive tract cancers , 2012, International journal of cancer.
[64] Bhuvanesh Singh,et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma , 2012, BMC Microbiology.
[65] P. Chaturvedi,et al. Arecanut as an emerging etiology of oral cancers in India , 2012, Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology.
[66] S. Hiremath,et al. Oral Cancer in India: An Epidemiologic and Clinical Review , 2012, Journal of Community Health.
[67] Rob Knight,et al. Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial Communities , 2011, Current protocols in bioinformatics.
[68] N. Johnson,et al. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. , 2011, Periodontology 2000.
[69] C. Huttenhower,et al. Metagenomic biomarker discovery and explanation , 2011, Genome Biology.
[70] A. Kruse,et al. Oral squamous cell carcinoma in non-smoking and non-drinking patients , 2010, Head & neck oncology.
[71] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[72] L. Turek,et al. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers , 2010, Cancer Causes & Control.
[73] Marina Mohd Bakri,et al. Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma , 2010, Journal of oral microbiology.
[74] Ning Ma,et al. BLAST+: architecture and applications , 2009, BMC Bioinformatics.
[75] Zlatko Trajanoski,et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] W. Wade,et al. A molecular analysis of the bacteria present within oral squamous cell carcinoma. , 2007, Journal of medical microbiology.
[77] C. Parish,et al. Th2-mediated anti-tumour immunity: friend or foe? , 2007, Tissue antigens.
[78] Eoin L. Brodie,et al. Greengenes: Chimera-checked 16S rRNA gene database and workbench compatible in ARB , 2006 .
[79] M. Posner,et al. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects , 2005, Journal of Translational Medicine.
[80] S. Kimura,et al. Streptococcus anginosus infection in oral cancer and its infection route. , 2005, Oral diseases.
[81] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[82] M. Terada,et al. Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer , 2003, Cancer science.
[83] Laurie H Glimcher,et al. A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.
[84] Y. Ko,et al. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[85] T. Aune,et al. Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. , 1989, The Journal of clinical investigation.
[86] J. T. Curtis,et al. An Ordination of the Upland Forest Communities of Southern Wisconsin , 1957 .
[87] B. Sampaio-Maia,et al. The Oral Microbiome in Health and Its Implication in Oral and Systemic Diseases. , 2016, Advances in applied microbiology.
[88] T. Wiele,et al. Microbiota and their role in the pathogenesis of oral mucositis. , 2015, Oral diseases.
[89] Robert C. Edgar,et al. BIOINFORMATICS APPLICATIONS NOTE , 2001 .
[90] Cancer.Net. , 2008, Journal of oncology practice.
[91] Christopher B Wilson,et al. Regulation of interferon-gamma during innate and adaptive immune responses. , 2007, Advances in immunology.
[92] A. Chao,et al. Nonparametric estimation of Shannon’s index of diversity when there are unseen species in sample , 2004, Environmental and Ecological Statistics.